Cargando…
Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781793/ https://www.ncbi.nlm.nih.gov/pubmed/10704054 |
_version_ | 1782131973015207936 |
---|---|
author | Pukhalsky, A L Kapranov, N I Kalashnikova, E A Shmarina, G V Shabalova, L A Kokarovtseva, S N Pukhalskaya, D A Kashirskaja, N J Simonova, O I |
author_facet | Pukhalsky, A L Kapranov, N I Kalashnikova, E A Shmarina, G V Shabalova, L A Kokarovtseva, S N Pukhalskaya, D A Kashirskaja, N J Simonova, O I |
author_sort | Pukhalsky, A L |
collection | PubMed |
description | Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy. |
format | Text |
id | pubmed-1781793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
record_format | MEDLINE/PubMed |
spelling | pubmed-17817932007-01-25 Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. Pukhalsky, A L Kapranov, N I Kalashnikova, E A Shmarina, G V Shabalova, L A Kokarovtseva, S N Pukhalskaya, D A Kashirskaja, N J Simonova, O I Mediators Inflamm Research Article Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy. 1999 /pmc/articles/PMC1781793/ /pubmed/10704054 Text en |
spellingShingle | Research Article Pukhalsky, A L Kapranov, N I Kalashnikova, E A Shmarina, G V Shabalova, L A Kokarovtseva, S N Pukhalskaya, D A Kashirskaja, N J Simonova, O I Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. |
title | Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. |
title_full | Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. |
title_fullStr | Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. |
title_full_unstemmed | Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. |
title_short | Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. |
title_sort | inflammatory markers in cystic fibrosis patients with lung pseudomonas aeruginosa infection. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781793/ https://www.ncbi.nlm.nih.gov/pubmed/10704054 |
work_keys_str_mv | AT pukhalskyal inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT kapranovni inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT kalashnikovaea inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT shmarinagv inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT shabalovala inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT kokarovtsevasn inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT pukhalskayada inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT kashirskajanj inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection AT simonovaoi inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection |